Pages
- About us
- Biological Product Analysis
- Cell-based bioassays and cell culture for biologics
- Certificates
- Consulting services
- Contact
- DNA and Protein Analysis by Electrophoresis
- Equipment
- Extractables and Leachables
- Facilities
- Galenical Development
- Gene Expression Analysis by qPCR (RT-qPCR)
- General usage conditions
- Home
- Import laboratory
- Microbiology
- Bacterial endotoxins test
- Bioburden testing
- Development and validation of microbiological methods
- Disinfectants qualification
- Efficacy of antimicrobial preservation
- Growth promotion test for culture media
- Microbiological identification
- Non-sterile products microbiological analysis
- Particle counting and environmental monitoring
- Sterility Test
- Netpharmalab at CPhI 2018, the Pharmaceutical event par excellence
- New Client Form
- News
- Physicochemical analysis
- Analysis of elemental impurities (ICP-MS)
- Development of analytical methods
- Identification and quantification of unknown impurities (LC-MS y GC-MS)
- Quality control and release of raw materials and finished products
- Routine analysis during pharmaceutical development phase
- Test of Nitrosamines
- Validation of analytical methods
- Privacy Policy
- Purity, Aggregates, and Stability Studies Analysis
- Quality Policy
- Sample Registration Form
- Stability studies
- Testing
- Thank you for contacting us
- Toxicology
- Viability, Proliferation and Cell Cytotoxicity Assays
- Work with Us
Posts by category
- Category: Sin categoría
- PK/PD bioanalysis of biological medicines during development
- Potency assays in biological products and their importance in quality control
- Protein aggregates in biological medicines and their impact on quality
- Peptide Mapping: What it is and why it is key for biologics
- Characterization of Therapeutic Proteins Using High-Resolution Mass Spectrometry
- A new identity for a company with greater capabilities
- Dissolution Problems: The silent challenge behind many successful reformulations
- The boom in complex generics is reshaping pharmaceutical development needs
- Chemical reverse engineering for identifying unknown impurities and solving complex problems
- USP 661.2: The Growth Driver of Extractables and Leachables
- Complex generics development in the European environment with new challenges and opportunities
- How the ICH M7 guideline regulates genotoxic impurities in the pharmaceutical industry
- Strengthening Control of Mutagenic Impurities and Nitrosamines (NDSRI) in the Pharmaceutical Industry
- Fundamentals of pharmaceutical lyophilization: Everything you need to know
- Galenical or Analytical Consulting? Benefits of Each and How They Complement Each Other
- How stability studies are conducted and what information they provide about a product
- What are Good Laboratory Practices (GLP) and why are they key to reliable results?
- Innovation in the development of semisolid pharmaceutical forms
- Analysis of genotoxic impurities in active pharmaceutical ingredients
- Microbiological analysis of non-sterile medicines
- The importance of routine analysis in pharmaceutical development
- How extractables and leachables studies improve the stability and safety of pharmaceutical products
- New USP Monograph: Requirements and Compliance for Pharmaceutical Plastic Packaging
- Optimization and advanced control in lyophilization processes
- Importance of In-Use Stability Testing in Pharmaceutical Development
- Pre-Stability Studies with Qualified Climatic Chambers
- 7 Things you should know about toxicological assessment in pharmaceutical process validation
- Galenical consulting as a key ally throughout the entire drug lifecycle
- Benefits of lyophilization in pharmaceutical products
- ICP-MS is the reference technique in the analysis of toxic impurities
- The importance of physicochemical analysis for drug quality
- Protecting patient health with mutagenic impurity analysis
- How ongoing stability studies improve the safety of medicines
- Impact of the ICH Q14 Framework on the Development and Validation of Analytical Methods
- EMA guidelines for the detection of nitrosamines in medicines
- Guide for the authorization of medicines at the EMA
- Authorization of veterinary medicines in the EU: Everything you need to know
- How to choose the righ external laboratory for pharmaceutical testing
- Netpharmalab strengthens its position with the acquisition of Docuchem
- Impact of the new ICH guidelines on quality control laboratories
- The importance of bioequivalence studies in the pharmaceutical industry
- Analysis of active ingredients for the production of medicines
- Stability Studies in Pharmaceuticals
- Mass Spectrometry in Drug Development Applications
- Extractables and Leachables study: protect your product from the packaging
- Bioburden Analysis for Pharmaceutical Safety and Quality
- Microbiological analysis of pharmaceutical products
- Innovations in Gene and Cell Therapies in Modern Medicine
- Messenger RNA Therapeutics Beyond COVID-19 Vaccines
- Sustainability in the Pharmaceutical Industry
- Good Manufacturing Practices for medicines
- Good Laboratory Practices in Pharmaceutical Testing
- Netpharmalab will be present at Farmaforum 2024
- Good manufacturing practice in the pharmaceutical industry
- General aspects of importing medicines into the European Union
- Sterility in medications and medical devices
- Toxicology in the pharmaceutical industry
- What are sterility areas in laboratories
- Toxicological risks in the production of medicines
- What are stability studies in the pharmaceutical sector
- What are biosimilars or biosimilar medicines
- Horizon 2030 where the pharmaceutical industry is going
- Impact of the new European legislation on the pharmaceutical industry
- International collaboration in pharmaceutical research
- Challenges and opportunities for the pharmaceutical industry after COVID-19
- The importance of pharmacovigilance
- Impact of medical cannabis regulation on the pharmaceutical industry
- Advances in vaccine development and research in Europe
- Control of nitrosamines in the pharmaceutical industry
- The Ministry of Health begins procedures to regulate medical cannabis
- What is galenical development in the pharmaceutical industry?
- Pharmaceutical lyophilization: what it is and what it is used for

